Healthequity Inc (HQY) CEO Jon Kessler Sells 1,332 Shares of Stock

Healthequity Inc (NASDAQ:HQY) CEO Jon Kessler sold 1,332 shares of the business’s stock in a transaction that occurred on Wednesday, February 14th. The shares were sold at an average price of $55.00, for a total value of $73,260.00. Following the transaction, the chief executive officer now owns 446,332 shares of the company’s stock, valued at approximately $24,548,260. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Jon Kessler also recently made the following trade(s):

  • On Friday, February 16th, Jon Kessler sold 20,442 shares of Healthequity stock. The shares were sold at an average price of $55.02, for a total value of $1,124,718.84.
  • On Thursday, January 25th, Jon Kessler sold 40,000 shares of Healthequity stock. The shares were sold at an average price of $49.47, for a total value of $1,978,800.00.

Shares of Healthequity Inc (NASDAQ:HQY) traded up $0.15 during mid-day trading on Friday, reaching $54.86. The company’s stock had a trading volume of 557,290 shares, compared to its average volume of 519,961. Healthequity Inc has a one year low of $37.62 and a one year high of $55.34. The firm has a market cap of $3,330.00, a price-to-earnings ratio of 74.14, a PEG ratio of 2.09 and a beta of 1.70.

Healthequity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The company had revenue of $56.80 million during the quarter, compared to analyst estimates of $55.27 million. During the same quarter in the previous year, the firm posted $0.10 EPS. The firm’s quarterly revenue was up 31.0% on a year-over-year basis. research analysts expect that Healthequity Inc will post 0.73 EPS for the current fiscal year.

A number of hedge funds have recently made changes to their positions in HQY. Carillon Tower Advisers Inc. bought a new stake in shares of Healthequity in the 4th quarter worth $34,100,000. Eagle Asset Management Inc. bought a new stake in shares of Healthequity in the 3rd quarter worth $36,875,000. Victory Capital Management Inc. raised its stake in shares of Healthequity by 116.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,031,711 shares of the company’s stock worth $48,139,000 after buying an additional 555,027 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Healthequity by 49.5% in the 3rd quarter. Wells Fargo & Company MN now owns 1,108,410 shares of the company’s stock worth $56,063,000 after buying an additional 366,925 shares in the last quarter. Finally, BlackRock Inc. raised its stake in shares of Healthequity by 3.8% in the 4th quarter. BlackRock Inc. now owns 6,751,491 shares of the company’s stock worth $315,026,000 after buying an additional 244,819 shares in the last quarter. Institutional investors own 98.63% of the company’s stock.

A number of research analysts recently issued reports on the company. BidaskClub upgraded Healthequity from a “hold” rating to a “buy” rating in a research report on Friday. Zacks Investment Research upgraded Healthequity from a “hold” rating to a “buy” rating and set a $57.00 price objective for the company in a research report on Saturday, February 10th. Robert W. Baird boosted their price objective on Healthequity from $48.00 to $49.00 and gave the company a “neutral” rating in a research report on Wednesday, February 7th. Cantor Fitzgerald boosted their price objective on Healthequity from $56.00 to $60.00 and gave the company an “overweight” rating in a research report on Wednesday, February 7th. Finally, JPMorgan Chase & Co. reduced their price target on Healthequity from $52.00 to $51.00 and set an “overweight” rating for the company in a research report on Wednesday, January 24th. One analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $56.67.

TRADEMARK VIOLATION NOTICE: “Healthequity Inc (HQY) CEO Jon Kessler Sells 1,332 Shares of Stock” was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://stocknewstimes.com/2018/02/17/healthequity-inc-hqy-ceo-jon-kessler-sells-1332-shares-of-stock.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply